13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2008-007447-14-IT (EUCTR) | 03/04/2009 | 26/03/2009 | GH-IGF-I status and Multiple Sclerosis: clinical implications (a prevalence study). | GH-IGF-I status and Multiple Sclerosis: clinical implications (a prevalence study). | patients with Multiple Sclerosis MedDRA version: 14.1;Level: SOC;Classification code 10022891;Term: Investigations;System Organ Class: 10022891 - Investigations MedDRA version: 14.1;Classification code 10014698;Term: Endocrine disorders;System Organ Class: 10014698 - Endocrine disorders;Therapeutic area: Diseases [C] - Hormonal diseases [C19] | INN or Proposed INN: Somatorelin | UNIVERSITA' DEGLI STUDI DI NAPOLI FEDERICO II | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Italy |